Similarly, olmesartan’s higher binding affinity for AT1 receptors might explain its association with gastrointestinal disorders like enteropathy, as its potent receptor blockade could influence intestinal permeability. This evidence concerns the gene AGTR1 and Abnormal intestine morphology.